Hims & Hers Health (HIMS) executive compensation, 2026 proxy

Andrew Dudum, Chief Executive Officer and Chairman, was paid $23M in 2025, down 7% from $24.6M the year before. The CEO-to-median-employee pay ratio was 272:1, on median employee pay of $84,402.

Filed
April 28, 2026
Annual meeting
June 11, 2026
Pay year
2025
Named executives
7
CEO total pay
$23M-7% vs prior year
CEO to median employee
272:1median $84,402
CEO pay in equity
94%$21.6M in awards
FY 2025 Revenue
$2.35 B59% YoY increase
FY 2025 Net Income
$128.4 MUp from 2024
Adjusted EBITDA
$318.0 MNon-GAAP financial measure
Operating Cash Flow
$300.0 MFor fiscal year 2025
Free Cash Flow
$57.4 MNon-GAAP financial measure

How Dudum was paid

$23M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary2%Stock awards46%Option awards48%Non-equity incentive3%All other compensation1%

Named executive officers

ExecutiveTotal
Andrew DudumChief Executive Officer and Chairman$22,958,907
Mr. OkupeChief Financial Officer$8,398,808
Mr. ElshenawyChief Technology Officer$60,869,746
Mr. ChiChief Operating Officer$7,727,713
Ms. BoughtonChief Legal Officer$4,796,709
Ms. BairdFormer Chief Operating Officer$8,392,871
Mr. KabbaniFormer Chief Operating Officer$14,862,305

What changed and why

  • $23MCEO total compensation decreased to $22,958,907 in 2025 from $24,609,077 in 2024.
  • $2.35BTotal FY 2025 revenue reached $2.35 billion, reflecting a 59% year-over-year increase.
  • $128.4MNet income for fiscal year 2025 was $128.4 million compared to $126.0 million in 2024.
  • $318.0MAdjusted EBITDA for fiscal year 2025 rose to $318.0 million from $176.9 million in 2024.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.